Keryx

Beleggen in aandelen beurs New York, Dow Jones index, Nasdaq-100 en S&P500
Plaats reactie
Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 18 Dec 2017 23:35

Bron : ST
Klopt volgende stelling ??

Sadie you seem like one of the most knowledgable here in the chat, do you have any numbers on how many weekly scripts the company needs just to break even? Thank you.

assuming burn out of $80M. assuming $450/script......3700/week
GALAPAGOS - This is just the beginning !


Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 19 Dec 2017 23:14

GALAPAGOS - This is just the beginning !

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 20 Dec 2017 12:32

Redelijke benadering ??
Bron ST

Sadie9 hours ago

Folks, lots of conjecture going on here post the 8k release. I’m posting a summary here of what I have said under several posts. In my opinion (and this is all opinion only), it makes sense for companies to tighten up their bylaws to reduce risk of both hostile takeovers as well as new activist investors who for all intensive purposes are forcing from the inside companies to sell (hostile takeover supported by activist shareholders from inside). There have been several high profile activist cases in the past couple of years and I have to assume me that any corporate lawyer worth their salt will advise their clients to reduce risk via bylaw changes. This I think is most likely simply a cleanup of legal documents,after review, to reduce risk

I think it is unlikely that we are seeing a new activist make a run at the board (at least not one that has made their purpose known yet) as we would have heard about it. Activists love to use the media to support their plans and we have not heard a whimper of such. Further with Baupost holding a majority position (with their position, plus convertible note and with Abrams) it would be very difficult for anyone else to attain a large enough voting block to force a sale. So while I do think we are seeing someone forcing the price lower to accumulate I am doubtful that it is in the form of hostile takeover.

More likely there is some shenanigans going on to try to get the company at as low a price as possible coupled with funds continuing to make money on the short side for as long as they can—though such will not be supported much longer with the continuing rise in scripts and the move towards positive cash flow at some point next year. Baupost is not stupid. Seth has a price target and when an offer comes that meets that target he will vote to sell. Until then we are all in a holding pattern and are dependent on the company moving into cash flow positive.
Revenge 2 liked last!
GALAPAGOS - This is just the beginning !

believer
Forum veteraan
Forum veteraan
Berichten: 1764
Lid geworden op: 14 Jan 2015 17:30
waarderingen: 949
Contact:

Re: Keryx

Berichtdoor believer » 20 Dec 2017 18:28

Daarnet 200000stuks in ene keer weg :D

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 21 Dec 2017 22:45

Bron : eigen berichtgeving Keryx

http://investors.keryx.com/phoenix.zhtm ... p=irol-sec

Entry into a Material Definitive Agreement.
On December 20, 2017, Keryx Biopharmaceuticals, Inc. (“Keryx”) and Siegfried Evionnaz SA, together with its affiliates and subsidiaries (collectively,
“Siegfried”), entered into a Master Manufacturing Services and Supply Agreement (the “Agreement”) for Siegfried to perform, directly or through its local
affiliate, certain manufacturing expansion services at its manufacturing facilities in Saint Vulbas, France and Pennsville, New Jersey (the “Manufacturing
Facilities”) as well as to manufacture and supply GMP-grade quantities of the proprietary active pharmaceutical ingredient (the “Product”) for Keryx’s drug
product, Auryxia.
Siegfried is responsible for procuring, commissioning and validating certain equipment at the Manufacturing Facilities in order to expand its operational
capacity (the “Expansion Services”), and Keryx will make a fixed lump sum payment (the “Service Payment”) to support such Expansion Services. Any
amounts required to finance the Expansion Services above the Service Payment will be paid by Siegfried.
Pursuant to the Agreement, Keryx has agreed to order a minimum quantity of Product annually. Siegfried has committed to achieve timely delivery of
Product and to accept all orders of Product from Keryx up to its operational capacity. After a specified time, Siegfried will issue a credit to Keryx if it has
failed to deliver a minimum percentage of the quantity of Product scheduled to be delivered monthly.
The Agreement has an initial term ending on December 31, 2021 and will automatically renew after the initial term for successive terms of one year each,
unless either party gives notice of its intention to terminate the Agreement within a specified time prior to the end of the then current term.
Keryx may terminate the Agreement upon sixty (60) days’ prior written notice due to certain regulatory authority action that prevents Keryx from
developing, importing, exporting, purchasing, selling or otherwise commercializing Auryxia in the United States.
Either Party may terminate the Agreement in the event of: (i) the cessation of all or substantially all of the other party’s business operations immediately upon
written notice, or (ii) a material breach or default, provided that such party has provided written notice and an opportunity to cure and the other party has not
cured such material breach or default within sixty (60) days of receipt of the notice. After a specified period, late delivery of Product for a certain number of
times within any 12-month period, which has not been cured within a specified time frame, constitutes a material breach by Siegfried. Additionally, either
party may terminate the Agreement upon thirty (30) days’ prior written notice if the other party (the “Bankrupt Party”) has become bankrupt or made an
assignment for the benefit of creditors, or there has been appointed a trustee for all or substantially all of the Bankrupt Party’s property, or any case or
proceeding has commenced or other action taken by or against the Bankrupt Party in bankruptcy or seeking reorganization, liquidation, dissolution,
winding-up, arrangement, composition or readjustment of its debts or any other relief under any bankruptcy, insolvency or reorganization or other similar act
of law.
The Agreement contains certain representations, warranties, limitations of liabilities, confidentiality and indemnity obligations, and other provisions
customary for agreements of this type.
The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by the full text of the Agreement, a copy of which
Keryx expects to file as an exhibit to Keryx’s Annual Report on Form 10-K for the year ended December 31, 2017.
charel01 liked last!
GALAPAGOS - This is just the beginning !

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 22 Dec 2017 00:11

charel01 liked last!
GALAPAGOS - This is just the beginning !

Gebruikersavatar
cicero007
Premiummember
Premiummember
Berichten: 962
Lid geworden op: 22 Mei 2013 09:31
waarderingen: 322
Contact:

Re: Keryx

Berichtdoor cicero007 » 22 Dec 2017 10:14

Laat ons een kip een kip noemen:
Het begint er hier dramatisch uit te zien...
Als zelfs week na week oplopende scripts de koers niet kunnen stutten, wat dan wel....
Revenge 2 liked last!
If you can't stand the heat, stay out of the kitchen ...

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 22 Dec 2017 15:12

Title: Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan's 36th Annual Healthcare Conference on January 10, 2018

Date(s): 22-Dec-2017 9:06 AM

For a complete listing of our news releases, please click here

BOSTON, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will webcast its corporate presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2018 at 11:30 a.m. PST (2:30 p.m. EST). In addition, the company will webcast the question & answer session immediately following its presentation at 12:00 p.m. PST (3:00 p.m. EST).
A live audio webcast of both the presentation and breakout session will be accessible from Keryx's website at http://investors.keryx.com within the Investor Relations section under "webcasts and presentations." Archived versions of the webcasts will be available for at least 15 days following the conclusion of each session.
Revenge 2 liked last!
GALAPAGOS - This is just the beginning !

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 22 Dec 2017 15:48

$1.49mm vs $1.31mm for Symphony
Revenge 2 liked last!
GALAPAGOS - This is just the beginning !

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 972
Lid geworden op: 21 Jan 2013 22:45
Locatie: Aardbol
waarderingen: 714
Contact:

Re: Keryx

Berichtdoor piddybull » 22 Dec 2017 16:21

Bron : kweet het begot zelf niet meer ;-)

https://docs.google.com/spreadsheets/d/ ... d=59787834
GALAPAGOS - This is just the beginning !